BDBM325828 4-(4-Fluorophenyl)-7-(((2S)-2-methyl-5(R)-(trifluoromethyl)piperazin-1-yl)methyl)quinoline-2-carboxamide::US9636337, 4-22- B
SMILES: C[C@H]1CN[C@H](CN1Cc1ccc2c(cc(nc2c1)C(N)=O)-c1ccc(F)cc1)C(F)(F)F
InChI Key: InChIKey=WEPMFGFQUDQCQI-YEJXKQKISA-N
Data: 2 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Metabotropic glutamate receptor 2 (Homo sapiens (Human)) | BDBM325828 (4-(4-Fluorophenyl)-7-(((2S)-2-methyl-5(R)-(trifluo...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as antagonists of metabotropic glutamate receptor activity, in particular mGluR... | US Patent US9663506 (2017) BindingDB Entry DOI: 10.7270/Q2PC34H4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 2 (Homo sapiens (Human)) | BDBM325828 (4-(4-Fluorophenyl)-7-(((2S)-2-methyl-5(R)-(trifluo...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as antagonists of metabotropic glutamate receptor activity, in particular mGluR... | US Patent US9636337 (2017) BindingDB Entry DOI: 10.7270/Q2F191TK | |||||||||||
More data for this Ligand-Target Pair |